B-cell lymphoma – Life with Disease

Go back

B-cell lymphoma is a type of blood cancer that develops in the lymphatic system, affecting white blood cells called lymphocytes. Understanding what lies ahead after a diagnosis can help patients and their families prepare emotionally and practically for the journey through treatment and beyond.

Prognosis and What to Expect

When someone receives a diagnosis of B-cell lymphoma, one of the first questions that naturally arises concerns the outlook for the future. The truth is that prognosis varies considerably depending on which specific type of B-cell lymphoma you have, how advanced the disease is at diagnosis, and how your body responds to treatment. This uncertainty can feel overwhelming, but understanding the general patterns can provide some reassurance.[1]

For many types of B-cell lymphoma, modern treatments have made a remarkable difference. More than half of all patients with aggressive B-cell lymphoma can now be cured, meaning the disease goes away completely and doesn’t return. When we talk about aggressive lymphomas like diffuse large B-cell lymphoma (the most common type), the word “aggressive” refers to how quickly the cancer grows, not necessarily how dangerous it is. With intensive treatment, these fast-growing types often respond very well.[7][12]

For patients with aggressive B-cell lymphomas, the five-year survival rate is over 60% overall, and more than 70% of patients can be cured with modern treatment approaches. These numbers represent real hope. However, it’s important to understand that most relapses, if they occur, happen within the first two years after therapy. After passing this milestone, the risk of the disease returning decreases significantly.[12]

The picture looks different for indolent (slow-growing) types of B-cell lymphoma. These conditions may not require immediate treatment and can have a relatively good prognosis with median survival as long as 20 years. However, they are usually not curable in advanced stages. This means patients may live with the disease for many years, undergoing treatment when needed to control symptoms, but the lymphoma may come back after periods of remission.[12]

One of the most important factors affecting prognosis is the stage at which lymphoma is diagnosed. Early-stage disease confined to one area generally has a better outlook than disease that has spread throughout the body. Your medical team will use several pieces of information to predict how your specific lymphoma might behave, including where it started, how far it has spread, your age, your overall health, and specific biological characteristics of the cancer cells themselves.[1]

⚠️ Important
While statistics provide general guidance, every person’s experience with B-cell lymphoma is unique. Your age, overall health, the specific subtype of lymphoma you have, and how the disease responds to treatment all influence your individual outlook. These factors mean that general statistics may not accurately predict your personal experience.

It’s worth noting that even when lymphoma can be cured, the treatment itself can put patients into long-term remission. Remission means that symptoms disappear and tests can’t find signs of cancer in your body. For some patients, remission lasts for the rest of their lives, effectively functioning as a cure. But lymphoma can come back, which doctors call recurrence or relapse, and this possibility means ongoing monitoring remains important even after successful treatment.[1]

How B-Cell Lymphoma Develops Without Treatment

Understanding what happens when B-cell lymphoma goes untreated helps explain why prompt medical attention matters, though it’s important to note that some slow-growing types are actually monitored without immediate treatment under a doctor’s careful supervision.

When aggressive B-cell lymphomas are left untreated, they can advance quickly because the abnormal cells multiply rapidly. These cancer cells don’t just stay in one place. B-cell lymphoma usually starts in the lymphatic system, which is a network of vessels and organs spread throughout your entire body. This network includes lymph nodes, the spleen, bone marrow, and other tissues. Because the lymphatic system extends everywhere, lymphoma cells can easily travel to different parts of the body.[1][2]

As the disease progresses without treatment, tumors made up of abnormal lymphocytes continue to grow. These growing tumors can cause lymph nodes to swell noticeably, particularly in the neck, armpits, or groin. But lymphoma can also develop in organs beyond the lymph nodes themselves. The stomach, lungs, skin, bones, brain, or essentially any organ in the body can become involved. When lymphoma spreads to areas outside the lymph nodes, doctors call these extranodal sites.[8]

For indolent types of B-cell lymphoma, the progression happens much more slowly. Some people live with slow-growing lymphoma for months or even years before experiencing any symptoms at all. In fact, follicular lymphoma, the second most common type of B-cell lymphoma, is often discovered accidentally when someone has tests or treatment for a completely unrelated medical condition. During this time, the lymphoma is present but growing so slowly that it doesn’t cause noticeable problems.[1]

Over time, even slow-growing lymphomas can progress if not monitored. The abnormal cells continue to multiply and crowd out the normal, healthy cells in your blood and bone marrow. This can eventually interfere with your body’s ability to fight infections, carry oxygen, and control bleeding. As the disease advances, it may spread to the bone marrow, liver, spleen, and other organs, potentially transforming from an indolent type into a more aggressive form.[6]

In some cases, an indolent B-cell lymphoma can undergo what doctors call transformation, changing into a more aggressive type. This transformation changes the behavior of the disease, making it grow faster and require more intensive treatment. Without medical intervention at this stage, the rapidly growing cells can severely impact organ function and overall health.[1]

Possible Complications That May Arise

B-cell lymphoma and its treatment can lead to various complications that affect different parts of your body and overall wellbeing. Understanding these possibilities helps patients recognize warning signs and seek help promptly when something doesn’t feel right.

One of the most serious potential complications relates to how lymphoma affects your immune system. Because B-cell lymphoma involves the white blood cells that normally fight infections, the disease itself weakens your body’s natural defenses. The abnormal lymphocytes can’t do their job of protecting you from germs, and they crowd out the healthy cells that would normally keep you safe from illness. This makes you more vulnerable to infections from bacteria, viruses, and other microorganisms.[1]

Treatment for lymphoma, particularly chemotherapy, further impacts your immune system. Chemotherapy drugs work by killing rapidly dividing cells, which includes cancer cells but also affects healthy cells in your bone marrow where blood cells are made. This can lead to dangerously low counts of white blood cells, red blood cells, and platelets. When white blood cell counts drop too low, even minor infections can become serious medical emergencies. Low red blood cell counts cause anemia, leading to profound fatigue and shortness of breath. When platelet counts fall, you may bruise easily or experience bleeding problems.[15]

Certain types of B-cell lymphoma carry specific risks depending on where they develop. For example, lymphoma that starts in or spreads to the brain and spinal cord (the central nervous system) can cause neurological complications including headaches, confusion, weakness, numbness, vision problems, or seizures. Lymphoma in the stomach or intestines may cause severe abdominal pain, bleeding, or blockages. When lymphoma affects the chest, it can press on airways or blood vessels, causing breathing difficulties or swelling in the face and arms.[6][16]

Some patients experience what doctors call infusion reactions during treatment, particularly with medications like rituximab. These reactions can range from mild symptoms like itching and rash to severe problems including difficulty breathing, chest pain, sudden drops in blood pressure, or irregular heartbeats. Most infusion reactions happen during the infusion itself or within 24 hours afterward. Healthcare teams give medications before treatment to reduce this risk, but patients need to know the warning signs and report any concerning symptoms immediately.[15]

A particularly concerning complication involves the reactivation of hepatitis B virus in patients who have previously been infected. Before starting treatment for B-cell lymphoma, doctors test for hepatitis B because the immunosuppressive effects of lymphoma treatment can allow this dormant virus to become active again. If hepatitis B reactivates, it can cause severe liver damage. This is why screening and monitoring are so important.[15]

Lung disorders represent another potential complication, particularly in elderly patients receiving intensive chemotherapy combinations. Damage to lung tissue can cause shortness of breath, cough, and reduced exercise tolerance. Heart problems may also develop, especially in patients receiving certain chemotherapy drugs or those who are older and have pre-existing heart conditions.[15]

Some complications affect the skin. Rarely, patients may develop severe skin reactions including painful sores or ulcers on the skin, lips, or inside the mouth. Blisters, peeling skin, rashes, or pustules can occur and require immediate medical attention as these can be signs of serious drug reactions.[15]

⚠️ Important
Contact your healthcare team immediately if you develop fever, signs of infection, unusual bleeding or bruising, severe shortness of breath, chest pain, new neurological symptoms, or severe skin reactions during or after lymphoma treatment. These complications often require urgent medical intervention but can be managed effectively when caught early.

Long-term complications may emerge years after successful treatment. Some patients experience fertility problems, particularly after exposure to certain chemotherapy drugs called alkylating agents. Young people who want to have children in the future should discuss fertility preservation options with their medical team before starting treatment.[12]

How B-Cell Lymphoma Affects Daily Life

Living with B-cell lymphoma changes many aspects of everyday life, touching everything from your physical abilities to your emotional wellbeing, relationships, work, and future plans. These changes don’t affect everyone the same way, and many people find ways to adapt and maintain meaningful, fulfilling lives despite the challenges.

The physical impact of B-cell lymphoma often appears before diagnosis and continues during treatment. Profound fatigue is one of the most common and challenging symptoms. This isn’t ordinary tiredness that improves with rest. It’s an overwhelming exhaustion that can make even simple tasks like getting dressed or preparing a meal feel impossibly difficult. Many patients describe feeling as though they’re moving through thick mud or carrying heavy weights all the time.[1]

Drenching night sweats can disrupt sleep, leaving you exhausted during the day. These aren’t mild episodes of perspiration but soaking sweats that require changing your nightclothes and sometimes even your bed sheets. Combined with other symptoms like abdominal pain, swollen lymph nodes, or shortness of breath, the physical burden of lymphoma before and during treatment can significantly limit what you’re able to do each day.[1][6]

Work life often requires adjustments. Some people can continue working during treatment, especially if their employer offers flexible arrangements like working from home or adjusting their schedule around medical appointments. However, many patients need to take extended time off. Treatment appointments themselves consume considerable time, with chemotherapy sessions, doctor visits, blood tests, and imaging scans filling your calendar. Recovery from intensive treatments may require weeks or months away from work.[21]

The emotional and psychological impact of living with lymphoma is profound and deserves just as much attention as physical symptoms. Receiving a cancer diagnosis often triggers intense fear, anxiety, and uncertainty about the future. You may worry about dying, about how treatment will affect you, about burdening your family, or about your ability to fulfill your responsibilities at work or home. These feelings are completely normal responses to a frightening situation.[21]

Many patients describe feeling as though their life is on hold while dealing with lymphoma. Plans you made for the future may need to change. Activities you enjoyed might become difficult or impossible during treatment. This sense of loss and disruption can lead to sadness or depression. Some people feel isolated, especially if friends and family members don’t understand what they’re experiencing or don’t know how to help.[18]

Relationships with family members, partners, and friends undergo changes too. Some relationships grow stronger as loved ones rally to support you, while others may become strained under the stress of illness. Your role in your family might shift if you can’t fulfill your usual responsibilities. Parents with lymphoma worry about how their illness affects their children. Partners may need to take on caregiving duties they never expected.[18]

Social activities and hobbies often require modification. During treatment, your immune system is compromised, so your medical team may recommend avoiding crowded places where you might catch infections. Physical activities you used to enjoy might be too tiring. Social gatherings can feel overwhelming when you’re dealing with symptoms and side effects. Many patients withdraw socially, not because they want to, but because they simply don’t have the energy or because they feel self-conscious about physical changes from treatment.[21]

Financial concerns add another layer of stress. Even with health insurance, cancer treatment can be expensive. Co-payments, deductibles, medications not fully covered by insurance, and travel costs for medical appointments add up quickly. If you need to reduce your work hours or stop working entirely, loss of income creates additional hardship. Many patients worry constantly about money while trying to focus on getting well.[21]

Practical daily life requires new approaches. Planning becomes essential because you need to schedule everything around medical appointments and manage your energy carefully. Some patients benefit from keeping a journal to track questions for their medical team and record what they’re told during appointments, as it’s hard to remember everything when you’re stressed. Creating simple plans for meals, childcare, transportation to appointments, and household tasks helps reduce the feeling that everything is out of control.[21]

Nutrition becomes both more important and more challenging. Your body needs good nutrition to handle treatment and heal, but nausea, changes in taste, or lack of appetite can make eating difficult. Some patients find that focusing on small, frequent meals works better than trying to eat three large meals a day. Having easy-to-prepare healthy foods available helps when you don’t have energy to cook.[20]

Many people find that maintaining some activities they enjoy, even in modified forms, helps them cope emotionally. If you loved walking but can’t manage long distances anymore, perhaps a short walk around the block brings some normalcy and pleasure. Staying connected to friends, even if just through phone calls or video chats when you can’t see them in person, helps combat isolation. Finding ways to continue participating in family life, even from the couch, maintains your sense of belonging and purpose.[18]

Most people describe going through a period of adjustment where they find their “new normal” while living with lymphoma. This takes time and patience with yourself. The initial shock and overwhelm gradually give way to developing routines and strategies that work for your situation. Many patients report that, although the experience is incredibly difficult, they also discover inner strength they didn’t know they had and develop deeper appreciation for what truly matters in life.[18]

Supporting Families Through the Clinical Trial Journey

For families facing B-cell lymphoma, clinical trials may emerge as an important consideration at various points in the treatment journey. Understanding what clinical trials involve and how family members can support a loved one considering trial participation helps everyone navigate this complex decision together.

Clinical trials are research studies that test new treatments or new ways of using existing treatments for lymphoma. For B-cell lymphoma specifically, hundreds of clinical trials are conducted to develop better, more effective approaches to treatment. These trials might test new chemotherapy drugs, innovative immunotherapies, targeted medications that attack specific features of lymphoma cells, or combinations of treatments used in new ways.[5]

Families should understand that clinical trials are carefully designed and regulated to protect patient safety while advancing medical knowledge. Before any trial begins, it must be approved by ethics committees that review the scientific plan and ensure adequate safeguards are in place. Doctors running the trial must provide detailed information about what the study involves, potential benefits, possible risks, and what other treatment options exist. Participation is always voluntary, and patients can withdraw from a trial at any time if they change their mind.[2]

One important role family members can play is helping to find relevant clinical trials. Not all trials are appropriate for every patient because trials have specific requirements about disease type, stage, previous treatments received, and other health conditions. Several resources make searching for trials easier. The Lymphoma TrialsLink database allows families to search specifically for lymphoma clinical trials. Major cancer centers often maintain lists of trials they’re conducting. The patient’s medical team can also provide information about trials they know of or help identify trials that might be suitable.[5]

When a potential trial is identified, family members can help by attending the consultation appointment where the trial is explained. Having an extra set of ears in the room helps because the patient may be too anxious or overwhelmed to absorb all the information. Family members can take notes, ask clarifying questions, and help remember important details later when decisions need to be made.

Good questions for families to ask about a clinical trial include: What is this trial trying to find out? What treatment will my loved one receive and how does it compare to standard treatment? What are the possible benefits and risks? How long will the trial last? Will there be extra appointments, tests, or procedures beyond what standard treatment requires? What happens if the treatment doesn’t work or causes serious side effects? Will we need to travel to a different medical center? What costs will be covered by the trial and what might we need to pay for?

Practical support from family becomes especially important if trial participation requires travel. Some trials are only available at specialized cancer centers that may be far from home. Family members might help arrange transportation, accompany the patient to appointments, assist with finding nearby accommodations if overnight stays are needed, or help manage the logistics of being away from home for extended periods.

Emotional support throughout the trial process matters tremendously. Deciding whether to participate in a clinical trial can be stressful. Some patients feel hopeful about accessing cutting-edge treatments, while others worry about unknown risks or feel anxious about being part of an experiment. Family members can help by listening without judgment, acknowledging these mixed feelings as completely normal, and supporting whatever decision the patient makes about participation.

If the patient decides to join a trial, family support continues throughout participation. Keeping track of appointment schedules, medication instructions, symptoms to report, and contact information for the research team helps manage the increased complexity that trials sometimes involve. Families can help monitor for side effects and encourage reporting of any concerning symptoms to the medical team.

It’s important for families to understand that participating in a clinical trial for lymphoma doesn’t mean giving up on proven treatments or serving as a “guinea pig.” Many trials compare a new treatment directly against the current standard treatment, so some participants receive standard care while others receive the experimental approach. In trials testing additional treatments, all participants typically receive standard therapy plus either the new treatment being studied or a placebo. The goal is always to find treatments that work better than what we have now.[16]

Finally, families should know that clinical trial participation benefits not just the individual patient but potentially helps many future patients with lymphoma. Every treatment we use today became available because previous patients volunteered to participate in the trials that tested those treatments. Even if a particular trial doesn’t help the patient who participates, the information gathered contributes to scientific understanding that may lead to better treatments later.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Rituximab (Rituxan) – A monoclonal antibody therapy that targets CD20 proteins on B-cells, commonly used in combination with chemotherapy for treating diffuse large B-cell lymphoma and other B-cell lymphomas
  • Cyclophosphamide (Cytoxan) – A chemotherapy drug used as part of the R-CHOP regimen for B-cell lymphoma treatment
  • Doxorubicin (Adriamycin) – An anthracycline chemotherapy drug that is a key component of combination chemotherapy for B-cell lymphoma
  • Vincristine (Oncovin) – A chemotherapy medication used in the R-CHOP treatment regimen for diffuse large B-cell lymphoma
  • Prednisone – A corticosteroid medication included in the R-CHOP and similar treatment combinations for B-cell lymphoma
  • Etoposide (Vepesid, Toposar, Etopophos) – A chemotherapy drug sometimes added to standard regimens to create R-CHOEP for certain B-cell lymphoma cases
  • Polatuzumab vedotin-piiq (Polivy) – A targeted therapy used in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone for treating diffuse large B-cell lymphoma
  • Ibrutinib (Imbruvica) – A targeted therapy studied for certain subtypes of diffuse large B-cell lymphoma, particularly the ABC subtype

Ongoing Clinical Trials on B-cell lymphoma

  • A study comparing AZD0486 after reduced chemotherapy versus standard chemotherapy in older or unfit patients with newly diagnosed large B-cell lymphoma

    Recruiting

    3 1 1 1
    Investigated diseases:
    Belgium Poland
  • Study of LUMC-BOB1-B7-TCR.

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on Immunotherapy with HSP-CAR19M and Drug Combination for Adults with B-cell Non-Hodgkin Lymphoma

    Recruiting

    2 1 1 1
    Spain
  • Study of IDP-121 for Patients with Relapsed or Refractory Multiple Myeloma, B-cell Lymphoma, or Chronic Lymphocytic Leukemia

    Recruiting

    2 1 1
    Investigated drugs:
    Spain
  • Study of valemetostat tosylate tablets in patients with relapsed or refractory B-cell lymphoma, including aggressive B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and Hodgkin lymphoma

    Recruiting

    2 1 1
    Belgium France
  • Long-Term Follow-Up Study for Patients Treated with CAR T-Cell Therapy Using PHE885, YTB323, and Tisagenlecleucel

    Recruiting

    3 1 1 1
    Austria Belgium Denmark Finland France Germany +6
  • Long-term Study of Ibrutinib for Patients with B-cell Non-Hodgkin’s Lymphoma and Chronic Graft Versus Host Disease

    Recruiting

    3 1 1 1
    Investigated drugs:
    Belgium France Germany Greece Italy Poland +2
  • Study on UCART20x22 for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Using a Drug Combination

    Recruiting

    2 1 1 1
    France Italy Spain
  • Study of Pembrolizumab for Children with Advanced Melanoma or PD-L1 Positive Solid Tumors and Lymphoma

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands Portugal Sweden
  • Study on the Safety and Effectiveness of AZD5492 Alone or with Other Treatments for Adults with Relapsed or Refractory B-Cell Blood Cancers

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark France Germany Italy Spain

References

https://my.clevelandclinic.org/health/diseases/22030-b-cell-lymphoma

https://www.mayoclinic.org/diseases-conditions/b-cell-lymphoma/symptoms-causes/syc-20586599

https://www.webmd.com/cancer/lymphoma/what-is-b-cell-lymphoma

https://www.cancer.org/cancer/types/non-hodgkin-lymphoma/about/b-cell-lymphoma.html

https://www.mdanderson.org/cancer-types/non-hodgkin-lymphoma/b-cell-lymphoma.html

https://www.cincinnatichildrens.org/health/b/b-cell-lymphoma

https://en.wikipedia.org/wiki/B-cell_lymphoma

https://lymphoma.org/understanding-lymphoma/aboutlymphoma/nhl/dlbcl/

https://www.mayoclinic.org/diseases-conditions/b-cell-lymphoma/diagnosis-treatment/drc-20586601

https://my.clevelandclinic.org/health/diseases/22030-b-cell-lymphoma

https://lymphoma.org/understanding-lymphoma/aboutlymphoma/nhl/dlbcl/dlbcltreatment/

https://www.cancer.gov/types/lymphoma/hp/aggressive-b-cell-lymphoma-treatment-pdq

https://www.masseycancercenter.org/cancer-types-and-treatments/cancer-types/non-hodgkin-lymphoma/treatment/

https://www.mdanderson.org/cancer-types/non-hodgkin-lymphoma/b-cell-lymphoma.html

https://www.rituxan.com/nhl/about-rituxan/diffuse-large-b-cell-lymphoma.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC3497705/

https://my.clevelandclinic.org/health/diseases/22030-b-cell-lymphoma

https://lymphoma-action.org.uk/about-lymphoma/living-and-beyond-lymphoma

https://www.cancercare.org/diagnosis/lymphoma

https://www.mylymphomateam.com/resources/diet-and-lymphoma-nutrition-tips-for-feeling-your-best

https://health.clevelandclinic.org/life-with-lymphoma

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Can B-cell lymphoma be cured?

Yes, many types of B-cell lymphoma can be cured, particularly aggressive types like diffuse large B-cell lymphoma. More than 70% of patients with aggressive B-cell lymphoma can be cured with intensive chemotherapy regimens. However, indolent (slow-growing) types are usually not curable in advanced stages, though patients can live for many years with the disease under control through periodic treatment.

What are the most common symptoms of B-cell lymphoma?

The most common symptoms include painless swelling of lymph nodes (particularly in the neck, armpits, or groin), profound fatigue, drenching night sweats, loss of appetite, and sometimes abdominal pain or shortness of breath. However, some people have no symptoms at all, especially with slow-growing types, and the lymphoma is discovered accidentally during tests for other reasons.

How long does treatment for B-cell lymphoma last?

Treatment duration varies by lymphoma type and treatment plan. For diffuse large B-cell lymphoma, the standard R-CHOP regimen typically involves up to 8 cycles of treatment, with each cycle lasting 21 days, meaning most people complete treatment in about 6 months. Some patients may receive fewer cycles, particularly if they have early-stage disease that responds well to treatment.

Will I be able to work during B-cell lymphoma treatment?

This depends on the type of treatment you receive, how you respond to it, and the nature of your work. Some people continue working with modifications like flexible schedules or remote work arrangements, while others need to take extended time off. Treatment appointments, side effects like fatigue, and compromised immune function during chemotherapy often make working difficult. It’s important to discuss work accommodations with your employer and medical team.

What’s the difference between aggressive and indolent B-cell lymphoma?

Aggressive B-cell lymphomas grow and spread quickly and require immediate, intensive treatment, but they often respond very well and can be cured. Indolent B-cell lymphomas grow slowly over months or years, may not need immediate treatment, and can have long survival times, but they are usually not curable and tend to come back after treatment. Despite the term “aggressive,” these faster-growing types often have better cure rates than indolent types.

🎯 Key takeaways

  • More than half of all patients with B-cell lymphoma can now be cured thanks to modern treatments, with aggressive types having cure rates exceeding 70%
  • Some types of B-cell lymphoma grow so slowly that people can live with them for years or even decades without symptoms or needing treatment
  • The addition of rituximab to chemotherapy revolutionized B-cell lymphoma treatment, significantly improving survival and cure rates
  • Most lymphoma relapses occur within the first two years after treatment, so passing this milestone significantly reduces recurrence risk
  • B-cell lymphoma affects more than just physical health – it impacts work, relationships, finances, and emotional wellbeing, requiring comprehensive support
  • Clinical trials offer access to cutting-edge treatments and contribute to advancing care for future lymphoma patients
  • Finding a medical team you trust and feel comfortable with is crucial since you’ll spend considerable time with them throughout your treatment journey
  • Building a strong support system of family, friends, and healthcare professionals helps navigate the emotional and practical challenges of living with lymphoma